Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 465, doi. 10.1007/s00262-015-1744-y
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2016 AND VI 65 AND IP 4
Results: 12
1
2
Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 417, doi. 10.1007/s00262-015-1750-0
- By:
- Publication type:
- Article
3
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 485, doi. 10.1007/s00262-015-1761-x
- By:
- Publication type:
- Article
4
Selection and expansion of natural killer cells for NK cell-based immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 477, doi. 10.1007/s00262-016-1792-y
- By:
- Publication type:
- Article
5
CD57 in human natural killer cells and T-lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 441, doi. 10.1007/s00262-016-1803-z
- By:
- Publication type:
- Article
6
A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17 cell frequency.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 393, doi. 10.1007/s00262-016-1805-x
- By:
- Publication type:
- Article
7
Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 427, doi. 10.1007/s00262-016-1806-9
- By:
- Publication type:
- Article
8
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 371, doi. 10.1007/s00262-016-1807-8
- By:
- Publication type:
- Article
9
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 383, doi. 10.1007/s00262-016-1809-6
- By:
- Publication type:
- Article
10
Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 405, doi. 10.1007/s00262-016-1811-z
- By:
- Publication type:
- Article
11
Natural killer cells, ageing and cancer.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
12
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 453, doi. 10.1007/s00262-015-1720-6
- By:
- Publication type:
- Article